Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SoftOx Solutions AS Director's Dealing 2022

Nov 3, 2022

3747_iss_2022-11-03_951a3343-3562-407a-b1ab-ec4959c00858.html

Director's Dealing

Open in viewer

Opens in your device viewer

SoftOx Solutions AS: Mandatory notification for close associate

SoftOx Solutions AS: Mandatory notification for close associate

Oslo, Norway, November 3, 2022: Geir H. Almås, CEO of SoftOx Solutions AS, a person discharging managerial responsibilities in SoftOx Solutions AS (the “Company”), has notified the Company of a transfer of a part of the convertible loan issued by the Company, as announced on October 11 2022.

Please refer to the attached form for further details about the transfer.

For further information, please contact:

CEO Geir Almås of SoftOx Solutions AS, or

CFO Kristine Rød of SoftfOx Solutions AS

Mail: [email protected]

Mobile: (+47) 948 59 599

The information included in this announcement is defined as inside information

pursuant to MAR article 7, and is publicly disclosed in accordance with MAR

article 17. The announcement is made by the contact person.

About SoftOx Solutions AS

SoftOx Solutions AS (SoftOx, listed on Euronext Growth Oslo) is a Norwegian

biopharmaceutical and MedTech company based in Oslo, with the goal of reducing

the spread of infection and emergence of antimicrobial resistance. For more

information on SoftOx, visit www.soft-ox.com